The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Resolvins suppress tumor growth and enhance cancer therapy
Open accessAbstract
Cancer therapy reduces tumor burden by killing tumor cells, yet it simultaneously creates tumor cell debris that may stimulate inflammation and tumor growth. Thus, conventional cancer therapy is inherently a double-edged sword. In this study, we show that tumor cells killed by chemotherapy or targeted therapy (“tumor cell debris”) stimulate primary tumor growth when coinjected with a subthreshold (nontumorigenic) inoculum of tumor cells by triggering macrophage proinflammatory cytokine release after phosphatidylserine exposure. Debris-stimulated tumors were inhibited by antiinflammatory and proresolving lipid autacoids, namely resolvin D1 (RvD1), RvD2, or RvE1. These mediators specifically inhibit debris-stimulated cancer progression by enhancing clearance of debris via macrophage phagocytosis in multiple tumor types. Resolvins counterregulate the release of cytokines/chemokines, including TNFα, IL-6, IL-8, CCL4, and CCL5, by human macrophages stimulated with cell debris. These results demonstrate that enhancing endogenous clearance of tumor cell debris is a new therapeutic target that may complement cytotoxic cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300 · cited 1×
“MAtErIALs And MEtHods tumor debris, xenograft, and metastasis studies Reporting of the following animal experiments abided by the Animal Research: Reporting of In Vivo Experiments (ARR IVE) guidelines (Kilkenny et al., 2010).”
InfluentialImproving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 2×
“Antitumor activity of resolvins is receptor dependent To confirm the specificity of resolvin action, we generated debris-stimulated and nondebris tumors in mice with a genetic deletion (KO) of the resolvin D1 receptor (ALX/ FPR2; Dufton et al., 2010), resolvin E1 receptor (ChemR23/ ERV; Arita et al., 2007), or resolvi…”
BackgroundPro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationHolmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationCaspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Identification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 730
Self-citationBirge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., Barcinski, M., Brekken, R. A., Huang, X., Hutchins, J. T., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.11 · Cited by 725
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695
Self-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationTIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells
Kobayashi, N., Karisola, P., Peña-Cruz, V., Dorfman, D. M., Jinushi, M., Umetsu, S. E., Butte, M. J., Nagumo, H., Chernova, I., Zhu, B., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.011 · Cited by 642
Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Self-citationZeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
Resolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
Self-citationAlarmins: awaiting a clinical response
Chan, J. K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N., & Nanchahal, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62423 · Cited by 511
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
Karagiannis, G. S., Pastoriza, J. M., Wang, Y., Harney, A. S., Entenberg, D., Pignatelli, J., Sharma, V. P., Xue, E. A., Cheng, E., D’Alfonso, T. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0026 · Cited by 497
Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
Garg, A. D., Nowis, D., Golab, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 496
A fate worse than death: apoptosis as an oncogenic process
Ichim, G., & Tait, S. W. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.58 · Cited by 451
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
Self-citationMelcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., & Vile, R. G. (1998) · Nature Medicine · doi:10.1038/nm0598-581 · Cited by 445
Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 421
Self-citationTitos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412
Identification of resolvin D2 receptor mediating resolution of infections and organ protection
Chiang, N., Dalli, J., Colas, R. A., & Serhan, C. N. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150225 · Cited by 383
Self-citationTodryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., & Vile, R. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1398 · Cited by 328
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Vyas, D., Laput, G., & Vyas, A. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s60114 · Cited by 310
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Pol, J., Vacchelli, E., Aranda, F., Castoldi, F., Eggermont, A., Cremer, I., Sautès-Fridman, C., Fucikova, J., Galon, J., Spisek, R., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008866 · Cited by 305
Regulation of inflammation in cancer by eicosanoids
Greene, E. R., Huang, S., Serhan, C. N., & Panigrahy, D. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.08.004 · Cited by 303
Self-citationDufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 302
Self-citationEpoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Panigrahy, D., Edin, M. L., Lee, C. R., Huang, S., Bielenberg, D. R., Butterfield, C. E., Barnés, C. M., Mammoto, A., Mammoto, T., Luria, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58128 · Cited by 294
Self-citationPisco, A. O., & Huang, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.146 · Cited by 283
Self-citationSchif‐Zuck, S., Gross, N., Assi, S., Rostoker, R., Serhan, C. N., & Ariel, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040801 · Cited by 237
Self-citationPaclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
Volk-Draper, L., Hall, K., Griggs, C., Rajput, S., Kohio, P., DeNardo, D., & Ran, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0067 · Cited by 234
Dromi, S. A., Walsh, M. P., Herby, S., Traughber, B., Xie, J., Sharma, K. V., Sekhar, K. P., Luk, A., Liewehr, D. J., Dreher, M. R., et al. (2009) · Radiology · doi:10.1148/radiol.2511072175 · Cited by 231
THE BIOLOGY OF CELL DEATH IN TUMOURS
Cooper, E. H. (1973) · Cell Proliferation · doi:10.1111/j.1365-2184.1973.tb01597.x · Cited by 222
Gregory, C. D., & Pound, J. D. (2011) · The Journal of Pathology · doi:10.1002/path.2792 · Cited by 215
Abubaker, K., Latifi, A., Luwor, R., Nazaretian, S., Zhu, H., Quinn, M. A., Thompson, E. W., Findlay, J. K., & Ahmed, N. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-24 · Cited by 213
Stuart, L. M., Takahashi, K., Shi, L., Savill, J., & Ezekowitz, R. A. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3220 · Cited by 205
Maderna, P., Yona, S., Perretti, M., & Godson, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3727 · Cited by 190
Self-citationBondanza, A., Zimmermann, V. S., Rovere-Querini, P., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W., Pöschl, E., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040327 · Cited by 175
Chang, Y. S., Jalgaonkar, S. P., Middleton, J. D., & Hai, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700455114 · Cited by 171
Wong, K., Valdez, P. A., Tan, C., Yeh, S., Hongo, J.-A., & Ouyang, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910929107 · Cited by 167
PGE2 induced in and released by dying cells functions as an inhibitory DAMP
Hangai, S., Ao, T., Kimura, Y., Matsuki, K., Kawamura, T., Negishi, H., Nishio, J., Kodama, T., Taniguchi, T., & Yanai, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602023113 · Cited by 161
Advancing science and technology via 3D culture on basement membrane matrix
Benton, G., George, J., Kleinman, H. K., & Arnaoutova, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21832 · Cited by 157
A therapeutic cancer vaccine against GL261 murine glioma
Kindy, M. S., Yu, J., Zhu, H., Smith, M. T., & Gattoni‐Celli, S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0757-9 · Cited by 144
Elajami, T. K., Colas, R. A., Dalli, J., Chiang, N., Serhan, C. N., & Welty, F. K. (2016) · The FASEB Journal · doi:10.1096/fj.201500155r · Cited by 143
Self-citationOncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
Ford, C. A., Petrova, S., Pound, J. D., Voss, J. J. L. P., Melville, L. A., Paterson, M., Farnworth, S. L., Gallimore, A., Cuff, S. M., Wheadon, H., et al. (2015) · Current Biology · doi:10.1016/j.cub.2014.12.059 · Cited by 140
Reiter, I., Krammer, B. E., & Schwamberger, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1730 · Cited by 139
He, J., Yin, Y., Luster, T. A., Watkins, L. R., & Thorpe, P. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1499 · Cited by 135
Ultrasound induced cancer immunotherapy
Unga, J., & Hashida, M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.004 · Cited by 133
Resolvin E1 and Chemokine-like Receptor 1 Mediate Bone Preservation
Gao, L., Faibish, D., Fredman, G., Herrera, B. S., Chiang, N., Serhan, C. N., Dyke, T. E. V., & Gyurko, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103688 · Cited by 131
Self-citationRévész, L. (1956) · Nature · doi:10.1038/1781391a0 · Cited by 116
Caspase 3 Promotes Surviving Melanoma Tumor Cell Growth after Cytotoxic Therapy
Donato, A. L., Huang, Q., Liu, X., Li, F., Zimmerman, M. A., & Li, C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.18 · Cited by 113
ELECTRON MICROSCOPE STUDIES OF EPIDERMAL MELANOCYTES, AND THE FINE STRUCTURE OF MELANIN GRANULES
Drochmans, P. (1960) · The Journal of Cell Biology · doi:10.1083/jcb.8.1.165 · Cited by 106
Akazawa, T., Masuda, H., Saeki, Y., Matsumoto, M., Takeda, K., Tsujimura, K., Kuzushima, K., Takahashi, T., Azuma, I., Akira, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1518 · Cited by 106
Macrophages orchestrate the immune response to tumor cell death.
Gough, M. J., Melcher, A. A., Ahmed, A. U., Crittenden, M. R., Riddle, D. S., Linardakis, E., Ruchatz, A., Emiliusen, L., & Vile, R. G. (2001) · PubMed · Cited by 104
Photodynamic therapy-generated vaccines: relevance of tumour cell death expression
Korbelik, M., Stott, B., & Sun, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604059 · Cited by 103
Number of apoptotic cells as a prognostic marker in invasive breast cancer
de Jong, J. S., van Diest, P. J., & Baak, J. P. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0928 · Cited by 99
Hosseini, H., Li, Y., Kanellakis, P., Tay, C., Cao, A., Tipping, P. G., Bobik, A., Toh, B. H., & Kyaw, T. S. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv037 · Cited by 98
Mochizuki, T., Kuge, Y., Zhao, S., Tsukamoto, E., Hosokawa, M., Strausś, H. W., Blankenberg, F. G., Tait, J. F., & Tamaki, N. (2003) · PubMed · Cited by 84
Gray, M. J., Gong, J., Hatch, M. M. S., Nguyen, V., Hughes, C. C. W., Hutchins, J. T., & Freimark, B. D. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0708-2 · Cited by 83
Liu, C., Cripe, T. P., & Kim, M. (2010) · Molecular Therapy · doi:10.1038/mt.2010.127 · Cited by 81
The biology of cell death in tumours.
Wyllie, A. H. (1985) · PubMed · Cited by 78
Parhar, R. S., & Lala, P. K. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.165.1.14 · Cited by 74
Deng, J., Zhang, Y., Feng, J., & Wu, F. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.12.004 · Cited by 70
Ej, O., Ca, E., & Hart, I. (1986) · PubMed · Cited by 68
CAR-T cell therapy seeks strategies to harness cytokine storm
DeFrancesco, L. (2014) · Nature Biotechnology · doi:10.1038/nbt0714-604 · Cited by 64
Silva, I., Chammas, R. J., Lepique, A. P., & Jancar, S. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.90 · Cited by 57
AnnexinA5 renders dead tumor cells immunogenic—implications for multimodal cancer therapies
Frey, B., Schildkopf, P., Rödel, F., Weiss, E., Munoz, L. E., i, M. H., Fietkau, R., & Gaipl, U. S. (2009) · Journal of Immunotoxicology · doi:10.3109/15476910903204058 · Cited by 54
The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages
Ley, S., Weigert, A., Weichand, B., Henke, N., Mille-Baker, B., Janssen, R. A. J., & Brüne, B. (2012) · Oncogene · doi:10.1038/onc.2012.77 · Cited by 53
Sato, N., Maehara, N., Mizumoto, K., Nagai, E., Yasoshima, T., Hirata, K., & Tanaka, M. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3<578::aid-cncr1037>3.0.co;2-w · Cited by 51
Poth, K. J., Guminski, A. D., Thomas, G. P., Leo, P. J., Jabbar, I. A., & Saunders, N. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0258 · Cited by 51
Gunjal, P., Schneider, G., Abdelbaset‐Ismail, A., Kakar, S. S., Kucia, M., & Ratajczak, M. Z. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0141-7 · Cited by 43
Microenvironmental Effects of Cell Death in Malignant Disease
Gregory, C. D., Ford, C. A., & Voss, J. J. L. P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_3 · Cited by 43
The role and prognostic value of apoptosis in colorectal carcinoma
Alcaide, J., Fúnez, R., Rueda, A., Pérez-Ruiz, E., Pereda, T., Rodrigo, I., Coveñas, R., Muñoz, M., & Redondo, M. (2013) · BMC Clinical Pathology · doi:10.1186/1472-6890-13-24 · Cited by 42
Yu, Y., Tian, L., Xiao, F., Cheng, J. Q., Gong, Y., Liu, X., Zhang, Z., Yang, X., He, S., Li, C., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.052 · Cited by 41
Stienstra, R., Dijk, W., van Beek, L., Jansen, H. J., Heemskerk, M. M., Houtkooper, R. H., Denis, S. W., van Harmelen, V., van Dijk, K. W., Tack, C. J., et al. (2014) · Diabetes · doi:10.2337/db14-0256 · Cited by 39
The immunological potential of apoptotic debris produced by tumor cells and during HIV infection
Kornbluth, R. S. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00149-9 · Cited by 38
Sun, B., Sun, Y., Wang, J., Zhao, X., Wang, X., & Hao, X. (2006) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000198896.02185.68 · Cited by 38
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.
Reers, S., Pfannerstill, A.-C., Rades, D., Maushagen, R., Andratschke, M., Pries, R., & Wollenberg, B. (2013) · PubMed · Cited by 33
Chaurio, R. A., Janko, C., Schorn, C., Maueröder, C., Bilyy, R. O., Gaipl, U. S., Schett, G. A., Berens, C., Frey, B., & Munoz, L. E. (2012) · Autoimmunity · doi:10.3109/08916934.2012.754433 · Cited by 30
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial
Grenon, S. M., Owens, C. D., Alley, H. F., Chong, K. C., Yen, P. K., Harris, W. S., Hughes‐Fulford, M., & Conte, M. S. (2013) · Vascular Medicine · doi:10.1177/1358863x13503695 · Cited by 29
Nadoushan, M. J., Peivareh, H., & Delshad, A. A. (2004) · Urology journal./Urology jornal. · Cited by 24
Tumor Biology: With a Little Help from My Dying Friends
Lauber, K., & i, M. H. (2015) · Current Biology · doi:10.1016/j.cub.2015.01.040 · Cited by 24
Shan, C., Shi, L., Ding, M., Zhu, Y., Li, X., Xu, B., Jiang, J., & Wu, C. (2015) · Oncology Letters · doi:10.3892/ol.2015.2977 · Cited by 23
Seelig, K. J., & Révész, L. (1960) · British Journal of Cancer · doi:10.1038/bjc.1960.15 · Cited by 21
A downside to apoptosis in cancer therapy?
Connell, P. P., & Weichselbaum, R. R. (2011) · Nature Medicine · doi:10.1038/nm0711-780 · Cited by 15
Cited by
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
The complex role of tumor-infiltrating macrophages
Christofides, A., Strauss, L., Yeo, A., Cao, C., Charest, A., & Boussiotis, V. A. (2022) · Nature Immunology · doi:10.1038/s41590-022-01267-2 · Cited by 849
Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., da Costa Souza, F., Dalli, J., Durand, T., Galano, J.-M., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 660
Self-citationLipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Metadata
- Authors
- Sulciner, M. L., Serhan, C. N., Gilligan, M. M., Mudge, D. K., Chang, J., Gartung, A., Lehner, K. A., Bielenberg, D. R., Schmidt, B., Dalli, J., Greene, E. R., Gus-Brautbar, Y., Piwowarski, J., Mammoto, T., Zurakowski, D., Perretti, M., Sukhatme, V. P., Kaipainen, A., Kieran, M. W., Huang, S., & Panigrahy, D.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-11-30
- Volume
- 215
- Issue
- 1
- Pages
- 115-140
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2771932310
- Cited by
- 256
- References
- 99
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.